The Precision Clot: Global Hemostatic Agents to Reach US$ 4.5...

agregó una foto Doğal Yaşam

2026-02-19 13:04:52 -

The Precision Clot: Global Hemostatic Agents to Reach US$ 4.5 Billion by 2031

In the high-stakes environment of the operating room, controlling blood loss is the primary determinant of patient recovery speed. Valued at US$ 2.6 Billion in 2022, the Global Hemostatic Agents Market is projected to grow to US$ 4.5 Billion by 2031, expanding at a CAGR of 6.2%. As of February 2026, the industry is witnessing a "Biological Pivot." While mechanical agents (like sponges) remain...

0 Commentarios 0 Acciones 425 Views 0 Vista previa